Rhonda L. Carter

1.2k total citations
33 papers, 948 citations indexed

About

Rhonda L. Carter is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Physiology. According to data from OpenAlex, Rhonda L. Carter has authored 33 papers receiving a total of 948 indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Molecular Biology, 12 papers in Cardiology and Cardiovascular Medicine and 9 papers in Physiology. Recurrent topics in Rhonda L. Carter's work include Receptor Mechanisms and Signaling (22 papers), Adenosine and Purinergic Signaling (8 papers) and Nitric Oxide and Endothelin Effects (5 papers). Rhonda L. Carter is often cited by papers focused on Receptor Mechanisms and Signaling (22 papers), Adenosine and Purinergic Signaling (8 papers) and Nitric Oxide and Endothelin Effects (5 papers). Rhonda L. Carter collaborates with scholars based in United States, Canada and Italy. Rhonda L. Carter's co-authors include Douglas G. Tilley, Donald H. Maurice, T. Kendall Harden, Walter J. Koch, Ingrid Fricks, Lindsay S. Wilson, Laurel A. Grisanti, Eduardo R. Lazarowski, Kenneth A. Jacobson and Daniel R. Raymond and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Circulation.

In The Last Decade

Rhonda L. Carter

32 papers receiving 941 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rhonda L. Carter United States 19 627 265 205 192 122 33 948
Takuro Numaga‐Tomita Japan 21 453 0.7× 123 0.5× 265 1.3× 143 0.7× 185 1.5× 32 994
Graeme Wilkinson United Kingdom 17 594 0.9× 392 1.5× 73 0.4× 266 1.4× 192 1.6× 27 1.0k
Normand McNicoll Canada 21 771 1.2× 72 0.3× 555 2.7× 216 1.1× 250 2.0× 34 1.4k
Monique Gastineau France 14 776 1.2× 33 0.1× 237 1.2× 344 1.8× 138 1.1× 19 1.1k
J. Christopher Hennings Germany 11 404 0.6× 56 0.2× 55 0.3× 182 0.9× 125 1.0× 16 846
Ludovic Gillet France 16 802 1.3× 70 0.3× 300 1.5× 203 1.1× 50 0.4× 21 1.1k
Malka Cohen‐Armon Israel 19 898 1.4× 137 0.5× 110 0.5× 256 1.3× 82 0.7× 43 1.5k
Giovanni Giurdanella Italy 23 564 0.9× 74 0.3× 33 0.2× 69 0.4× 93 0.8× 48 1.3k
Tonia E. Tse United States 11 657 1.0× 47 0.2× 82 0.4× 268 1.4× 276 2.3× 12 1.2k
Rita I. Jabr United Kingdom 20 461 0.7× 61 0.2× 287 1.4× 104 0.5× 158 1.3× 42 1.1k

Countries citing papers authored by Rhonda L. Carter

Since Specialization
Citations

This map shows the geographic impact of Rhonda L. Carter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rhonda L. Carter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rhonda L. Carter more than expected).

Fields of papers citing papers by Rhonda L. Carter

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rhonda L. Carter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rhonda L. Carter. The network helps show where Rhonda L. Carter may publish in the future.

Co-authorship network of co-authors of Rhonda L. Carter

This figure shows the co-authorship network connecting the top 25 collaborators of Rhonda L. Carter. A scholar is included among the top collaborators of Rhonda L. Carter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rhonda L. Carter. Rhonda L. Carter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Nayak, Tapas Kumar, et al.. (2023). Myeloid cell-specific deletion of epidermal growth factor receptor aggravates acute cardiac injury. Clinical Science. 137(19). 1513–1531. 3 indexed citations
3.
Guo, Shuchi, Rhonda L. Carter, Toby P. Thomas, et al.. (2021). Epidermal growth factor receptor-dependent maintenance of cardiac contractility. Cardiovascular Research. 118(5). 1276–1288. 14 indexed citations
4.
Castro, Sonia de, Mario Grifantini, Serge Van Calenbergh, et al.. (2020). Synthesis and potency of novel uracil nucleotides and derivatives as P2Y2 and P2Y6 receptor agonists. UNC Libraries. 2 indexed citations
5.
Guo, Shuchi, et al.. (2020). Epidermal growth factor receptor association with β1-adrenergic receptor is mediated via its juxtamembrane domain. Cellular Signalling. 78. 109846–109846. 3 indexed citations
6.
Pfleger, Jessica, Polina Gross, Jaslyn Johnson, et al.. (2018). G protein-coupled receptor kinase 2 contributes to impaired fatty acid metabolism in the failing heart. Journal of Molecular and Cellular Cardiology. 123. 108–117. 21 indexed citations
7.
Guo, Shuchi, Rhonda L. Carter, Laurel A. Grisanti, Walter J. Koch, & Douglas G. Tilley. (2017). Impact of paroxetine on proximal β-adrenergic receptor signaling. Cellular Signalling. 38. 127–133. 18 indexed citations
8.
Grisanti, Laurel A., Jianliang Song, Rhonda L. Carter, et al.. (2016). Vasopressin type 1A receptor deletion enhances cardiac contractility, β-adrenergic receptor sensitivity and acute cardiac injury-induced dysfunction. Clinical Science. 130(22). 2017–2027. 7 indexed citations
9.
Carr, Richard W., Justin Schilling, Jianliang Song, et al.. (2016). β-arrestin–biased signaling through the β2-adrenergic receptor promotes cardiomyocyte contraction. Proceedings of the National Academy of Sciences. 113(28). E4107–16. 82 indexed citations
10.
Deliu, Elena, Linda Console‐Bram, Rhonda L. Carter, et al.. (2015). The Lysophosphatidylinositol Receptor GPR55 Modulates Pain Perception in the Periaqueductal Gray. Molecular Pharmacology. 88(2). 265–272. 48 indexed citations
11.
Grisanti, Laurel A., Rhonda L. Carter, Justine Yu, et al.. (2014). β-Adrenergic receptor-mediated transactivation of epidermal growth factor receptor decreases cardiomyocyte apoptosis through differential subcellular activation of ERK1/2 and Akt. Journal of Molecular and Cellular Cardiology. 72. 39–51. 38 indexed citations
12.
Grisanti, Laurel A., et al.. (2014). Temporal and gefitinib-sensitive regulation of cardiac cytokine expression via chronic β-adrenergic receptor stimulation. American Journal of Physiology-Heart and Circulatory Physiology. 308(4). H316–H330. 23 indexed citations
13.
Tilley, Douglas G., Weizhong Zhu, Valerie D. Myers, et al.. (2014). β-Adrenergic Receptor–Mediated Cardiac Contractility Is Inhibited via Vasopressin Type 1A-Receptor–Dependent Signaling. Circulation. 130(20). 1800–1811. 31 indexed citations
14.
Carter, Rhonda L., et al.. (2014). β-Adrenergic Receptor-Dependent Alterations in Murine Cardiac Transcript Expression Are Differentially Regulated by Gefitinib In Vivo. PLoS ONE. 9(6). e99195–e99195. 8 indexed citations
15.
Yu, Justine, Elena Deliu, Nicholas E. Hoffman, et al.. (2013). Differential Activation of Cultured Neonatal Cardiomyocytes by Plasmalemmal Versus Intracellular G Protein-coupled Receptor 55. Journal of Biological Chemistry. 288(31). 22481–22492. 34 indexed citations
16.
Carter, Rhonda L., Ingrid Fricks, Matthew O. Barrett, et al.. (2009). Quantification of Gi-Mediated Inhibition of Adenylyl Cyclase Activity Reveals That UDP Is a Potent Agonist of the Human P2Y14 Receptor. Molecular Pharmacology. 76(6). 1341–1348. 70 indexed citations
17.
Calenbergh, Serge Van, Bhalchandra V. Joshi, Hyojin Ko, et al.. (2009). Synthesis and P2Y receptor activity of nucleoside 5′-phosphonate derivatives. Bioorganic & Medicinal Chemistry Letters. 19(11). 3002–3005. 18 indexed citations
18.
Ko, Hyojin, Arijit Das, Rhonda L. Carter, et al.. (2009). Molecular recognition in the P2Y14 receptor: Probing the structurally permissive terminal sugar moiety of uridine-5′-diphosphoglucose. Bioorganic & Medicinal Chemistry. 17(14). 5298–5311. 32 indexed citations
19.
Ko, Hyojin, Rhonda L. Carter, Riccardo Petrelli, et al.. (2008). Synthesis and potency of novel uracil nucleotides and derivatives as P2Y2 and P2Y6 receptor agonists. Bioorganic & Medicinal Chemistry. 16(12). 6319–6332. 63 indexed citations
20.
Fricks, Ingrid, Savitri Maddileti, Rhonda L. Carter, et al.. (2008). UDP Is a Competitive Antagonist at the Human P2Y14 Receptor. Journal of Pharmacology and Experimental Therapeutics. 325(2). 588–594. 46 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026